共 9 条
- [2] Patient Survival and Prevalence of Substance Use at the Time of Left Ventricular Assist Device Implantation and at One Year Post Implant JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2023, 42 (04): : S338 - S339
- [6] Two-Year Outcomes in the Destination Therapy Post-FDA-Approval Study with a Continuous Flow Left Ventricular Assist Device: A Prospective Study Using the INTERMACS Registry JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2013, 32 (04): : S10 - S10
- [8] Comorbidities and the decision to undergo or forego destination therapy left ventricular assist device implantation: An analysis from the Trial of a Shared Decision Support Intervention for Patients and their Caregivers Offered Destination Therapy for End-Stage Heart Failure (DECIDE-LVAD) study AMERICAN HEART JOURNAL, 2019, 213 : 91 - 96
- [9] Clinically Important Differences Are Useful for Interpreting Patient-Reported Outcomes Measurement Information System (PROMIS) Measures After Left Ventricular Assist Device (LVAD) Implantation: Findings from the Mechanical Circulatory Support: Measures of Adjustment and Quality of Life (MCS A-QOL) Study JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2022, 41 (04): : S163 - S164